Hsp90 as a target molecule for selective therapy in FLT3 positive AML

被引：0
|
作者：
Al-Shaer, LM [1 ]
Rowntree, CJ [1 ]
Mills, KI [1 ]
Tonks, A [1 ]
Darley, RL [1 ]
Burnett, AK [1 ]
机构：
[1] UWCM, Dept Haematol, Cardiff, S Glam, Wales
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
57
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy
    Naoe, T
    Kiyoi, H
    Yamamoto, Y
    Minami, Y
    Yamamoto, K
    Ueda, R
    Saito, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (Suppl 1) : S27 - S30
  • [2] FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy
    Tomoki Naoe
    Hitoshi Kiyoi
    Yukiya Yamamoto
    Yosuke Minami
    Kazuhito Yamamoto
    Ryuzo Ueda
    Hidehiko Saito
    Cancer Chemotherapy and Pharmacology, 2001, 48 : S27 - S30
  • [3] The Role of FLT3 Kinase as an AML Therapy Target
    Beffinger, Micha
    Skwarska, Anna
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (19) : 2758 - 2765
  • [4] Heat shock protein 90 (Hsp90) inhibition results in apoptotic killing of primary AML cells with FLT3/ITD mutation.
    Al-Shaer, LM
    Gilkes, AF
    Mills, KI
    Burnett, AK
    Rowntree, CJ
    BLOOD, 2004, 104 (11) : 692A - 692A
  • [5] ETV6/FLT3 Fusion Is a Novel Client Protein of Hsp90
    Bui Thi Kim Ly
    Hoang Thanh Chi
    ONCOLOGY RESEARCH, 2018, 26 (08) : 1201 - 1205
  • [6] HSP90 inhibitors overcome drug resistance caused by FLT3 kinase domain mutations
    Yu, C.
    Kancha, R. K.
    Duyster, J.
    ONKOLOGIE, 2013, 36 : 209 - 209
  • [7] Incorporating a FLT3 inhibitor into AML therapy
    Levis, M. J.
    Small, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD-positive AML
    Cortes, Jorge
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [9] Targeted Therapy of FLT3 mutated AML
    Fiedler, W.
    Heuser, M.
    Kayser, S.
    Kebenko, M.
    Krauter, J.
    Salih, H. R.
    Goetze, K.
    Stamm, H.
    Latuske, E.
    Wellbrock, J.
    Doehner, K.
    Ganser, A.
    Doehner, H.
    Schlenk, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 21 - 21
  • [10] Hsp90: A novel target for cancer therapy
    Solit, David B.
    Rosen, Neal
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (11) : 1205 - 1214
12345